Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,353,334
+$328,766 QoQ
Shares Held
52,618
-1.4% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#113
of 290 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. DNLI ranks #140 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in DNLI
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,353,334 | 52,618 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,024,568 | 53,363 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $900,503 | 54,543 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $860,075 | 59,234 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $79,249,612 | 5,664,733 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $155,113,481 | 11,409,598 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $200,701,238 | 9,847,951 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $312,490,616 | 10,727,450 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $228,107,867 | 9,823,767 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $169,699,351 | 8,269,949 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $156,115,424 | 7,274,717 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $150,371,242 | 7,288,960 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $207,696,572 | 7,038,176 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $119,818,596 | 5,200,460 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $142,435,308 | 5,121,730 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $665,788 | 21,694 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||